Analyst Travis Steed of Bank of America Securities maintained a Buy rating on Medtronic (MDT – Research Report), retaining the price ...

Medtronic PLC closed $2.15 below its 52-week high ($91.49), which the company reached on September 4th.

Medtronic (NYSE: MDT) has named Jorie Soskin as its new VP and GM of its TAVR and Congenital Heart businesses.

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Shares of Medtronic PLC MDT advanced 1.52% to $89.47 Thursday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500 Index SPX rising 1.70% to 5,713.64 ...

California-based medical device company Axonics has won a patent infringement trial against Medtronic, according to a Sept. 19 report from Global Data. Medtronic alleged that the company copied three ...

A federal jury in California has found that Axonics’ neurostimulators and electric leads for treating incontinence do not run ...

12 ceremony. Axonics Inc. (Nasdaq: AXNX), a maker of medical devices to treat incontinence, said a jury has returned a ...

The company published trial design and preliminary data from the adaptive DBS algorithm for personalised therapy in Parkinson’s disease (ADAPT-PD) trial.

BlueWind Medical, a pioneer in implantable Tibial NeuroModulation (iTNM) and the developer of Revi®, a patient-centric ...

Medtronic, a global developer and manufacturer of medical devices for chronic diseases, is now a $111 billion (by market cap) ...